Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announced that it has extended its collaboration agreement with its partner, a world leader in animal health.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2016/06/QUANTUM_CP_Collaboration-santé-animale_28062016_VDEF_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
